BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Bayer Acquires Noria, PSMA Therapeutics to Expand Place in Prostate Cancer Space

  Bayer will nab exclusive rights to a differentiated alpha radionuclide, actinium-225 investigational compound, and a small molecule targeting prostate-specific membrane antigen.

  June 4, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  FDA

  CVR Holders Slap BMS with Lawsuit After Missed Liso-Cel Deadline

  It didn’t take too long before a lawsuit was filed over Bristol Myers Squibb’s failure to meet a deadline for a $9 Contingent Value Rights agreement tied to the company’s merger with Celgene.

  June 4, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  FDA Action Alert: Alexion, Biogen, Vertex and Royalty

  June is turning out to be a busy month for PDUFA dates for the U.S. Food and Drug Administration. Here’s a look at this week’s dates.

  June 4, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  Another COVID-19 Win for Regeneron as FDA Okays Lower Dose of Antibody Cocktail

  REGEN-COV’s 1,200 mg dose is authorized to treat mild-to-moderate COVID-19 in adults and children 12 years and older who weigh 40 kilograms or more.

  June 4, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Nanobiotix’s Radiotherapy Enhancer NBTXR3 for Tumors Also Primes the Immune System

  Nanobiotix is developing a way for its locally-injected radio enhancer NBTXR3 for solid tumors to treat metastasized cancers. Here’s what you need to know about it.

  June 4, 2021

   · 

  5 min read

   · 

  Gail Dutton
• 

  Business

  Global Acceptance for Sinovac’s COVID-19 Vaccine Grows Despite Disparate Data

  While several countries rely on Sinovac Biotech to end the pandemic, concerns regarding the shot’s efficacy continue to shroud the vaccine. Currently, it is the second most used vaccine worldwide.

  June 4, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  Drug Development

  ASCO Update: A Theme of Accessibility and Pricing Plus Individual Reporting

  With the 2021 American Society of Clinical Oncology Annual Meeting now in high gear, there is plenty of news. Here’s a look at just some of the most recent stories.

  June 4, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Employer Resources

  How to Write an Effective Pharmaceutical Job Description with Sample

  Like in writing any job description, composing one for a pharmaceutical job offering must contain all the information a candidate must know.

  June 4, 2021

   · 

  5 min read

   · 

  Lorenzo Soliman
• 

  Drug Development

  Clinical Catch-Up: June 1-6

  With the 2021 American Society of Clinical Oncology meeting held late last week, there is plenty of clinical trial news.

  June 4, 2021

   · 

  7 min read

   · 

  Mark Terry
• 

  Genetown

  Cellarity: Transforming Drug Development at the Confluence of Biology and Machine Learning

  In the field of drug discovery, one must always begin with the target, right? Not if you ask Cellarity, a quickly emerging biotech company revolutionizing the drug development space.

  June 4, 2021

   · 

  5 min read

   · 

  Heather McKenzie